Back
Fulcrum Therapeutics Vs. GitLab Industry Stock Comparison
Buy
61
FULC
Fulcrum Therapeutics
Last Price:
$7.65
Seasonality Move:
24.14%
Buy
63
GTLB
GitLab
Last Price:
$45.38
Seasonality Move:
-8.13%
Buy
61
Fulcrum Therapeutics (FULC)
is a Buy
Is Fulcrum Therapeutics a Buy, Sell or Hold?
-
The current Fulcrum Therapeutics [FULC] share price is $7.65. The Score for FULC is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
FULC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FULC Stock Price Chart
What is Fulcrum Therapeutics's stock price today?
-
The Fulcrum Therapeutics share price today is $7.65Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FULC is experiencing selling pressure, which indicates risk of future bearish movement.
FULC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.18 | Buy |
Relative Strength Index (14 RSI): | 58.54 | Buy |
Chaikin Money Flow: | -363618 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.76 - 7.76) | Buy |
Bollinger Bands (100): | (3.2 - 7) | Buy |
GTLB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 12.19 | Buy |
Relative Strength Index (14 RSI): | 53.02 | Buy |
Chaikin Money Flow: | 3175298 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.87 - 45.63) | Buy |
Bollinger Bands (100): | (42.58 - 52.82) | Sell |
FULC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.87 | Sell |
20-day SMA: | 7.42 | Buy |
50-day SMA: | 6.87 | Buy |
200-day SMA: | 4.46 | Buy |
8-day EMA: | 7.02 | Buy |
20-day EMA: | 4.66 | Buy |
50-day EMA: | 2.38 | Buy |
200-day EMA: | 0.68 | Buy |
GTLB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 43.92 | Buy |
20-day SMA: | 44.14 | Buy |
50-day SMA: | 46.14 | Sell |
200-day SMA: | 54.34 | Sell |
8-day EMA: | 39.4 | Buy |
20-day EMA: | 26.16 | Buy |
50-day EMA: | 13.35 | Buy |
200-day EMA: | 3.8 | Buy |
Fulcrum Therapeutics Earnings Growth & FULC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, an increase next quarter of $0.37 per share, a decrease this year of $1.00 per share, and a decrease next year of $0.06 per share.
GitLab Earnings Growth & GTLB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.02 per share, an increase this year of $0.50 per share, and an increase next year of $0.12 per share.
Fulcrum Therapeutics Technical Analysis
Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
GitLab Technical Analysis
Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |